Predictive Factors of Oncologic Outcomes in Patients Who do not Achieve Undetectable Prostate Specific Antigen after Radical Prostatectomy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive Factors of Oncologic Outcomes in Patients Who do not Achieve Undetectable Prostate Specific Antigen after Radical Prostatectomy

Published:2013-11 Issue:5 Volume:190 Page:1750-1756
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Ploussard Guillaume¹,Staerman Frédéric²,Pierrevelcin Jean²,Saad Rodrigue¹,Beauval Jean-Baptiste³,Roupret Morgan⁴,Audenet François⁴,Peyromaure Mickaël⁵,Barry Delongchamps Nicolas⁵,Vincendeau Sébastien⁶,Fardoun Tarek⁶,Rigaud Jérôme⁷,Villers Arnauld⁸,Bastide Cyrille⁹,Soulie Michel³,Salomon Laurent¹,

Affiliation:

1. Department of Urology, Henri Mondor Academic Hospital, Créteil, France

2. Departments of Urology and Andrology, Robert Debré Academic Hospital, Reims, France

3. Department of Urology, Centre Hospitalier Universitaire Rangueil, Toulouse, France

4. Department of Urology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

5. Department of Urology, Hospital Cochin, Paris, France

6. Department of Urology, Hospital Pontchaillou, Rennes, France

7. Department of Urology, Hotel Dieu, Nantes, France

8. Department of Urology, Centre Hospitalier Universitaire Lille, Lille, France

9. Department of Urology, Hospital Nord, Marseille, France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference28 articles.

1. Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival;Doherty;Br J Cancer,2000

2. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy;Shen;J Urol,2005

3. Detectable prostate-specific antigen level between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance;Sengupta;J Urol,2006

4. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

5. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy;Rogers;Cancer,2004

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of risk factors for persistent PSA after radical prostatectomy: results from a high-volume center in Southeast China;BMC Urology;2024-08-29

2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent;European Urology;2024-08

3. Analysis of risk factors for disease progression after salvage radiation therapy with androgen deprivation therapy in prostate cancer patients who have prostate-specific antigen persistence after radical prostatectomy;Radiation Oncology Journal;2024-06-30

4. Impact of persistent PSA after salvage radical prostatectomy: a multicenter study;Prostate Cancer and Prostatic Diseases;2023-10-06

5. Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma;Oncology Reviews;2023-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3